These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 15765779

  • 21. Is splenectomy necessary for immune thrombocytopenic purpura? The role of rituximab in patients with corticosteroid resistance in a single-center experience.
    Zhang C, Liu HF, Chen XH, Gao L, Gao L, Liu Y, Kong PY, Sun AH, Zhang X.
    Clin Ther; 2014 Mar 01; 36(3):385-8. PubMed ID: 24594069
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [New treatment methods for autoimmune thrombocytopenia].
    Koene HR.
    Ned Tijdschr Geneeskd; 2007 Nov 24; 151(47):2609-14. PubMed ID: 18161261
    [Abstract] [Full Text] [Related]

  • 24. Emerging strategies to treat chronic immune thrombocytopenic purpura.
    Newland A.
    Eur J Haematol Suppl; 2008 Feb 24; (69):27-33. PubMed ID: 18211570
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Current therapies in primary immune thrombocytopenia.
    Pels SG.
    Semin Thromb Hemost; 2011 Sep 24; 37(6):621-30. PubMed ID: 22102265
    [Abstract] [Full Text] [Related]

  • 27. Management of adult idiopathic thrombocytopenic purpura.
    Cines DB, McMillan R.
    Annu Rev Med; 2005 Sep 24; 56():425-42. PubMed ID: 15660520
    [Abstract] [Full Text] [Related]

  • 28. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
    Kolonić SO, Patekar MB, Milunović V.
    Acta Med Croatica; 2013 Mar 24; 67(1):3-11. PubMed ID: 24279250
    [Abstract] [Full Text] [Related]

  • 29. Treatment of a patient with chronic immune thrombocytopenic purpura with rituximab and monitoring by flow cytometric analysis.
    Thude H, Gruhn B, Werner U, Schorner U, Häfer R, Zintl F, Barz D.
    Acta Haematol; 2004 Mar 24; 111(4):221-4. PubMed ID: 15153715
    [Abstract] [Full Text] [Related]

  • 30. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.
    Stasi R, Pagano A, Stipa E, Amadori S.
    Blood; 2001 Aug 15; 98(4):952-7. PubMed ID: 11493438
    [Abstract] [Full Text] [Related]

  • 31. Reassessment of treatment modalities for paediatric patients with chronic immune thrombocytopenia.
    Laws HJ, Janssen G, Borkhardt A.
    Hamostaseologie; 2009 May 15; 29(2):171-6. PubMed ID: 19404521
    [Abstract] [Full Text] [Related]

  • 32. Rituximab: an anti-CD20 antibody for the treatment of chronic refractory immune thrombocytopenic purpura.
    Aggarwal A, Catlett JP.
    South Med J; 2002 Oct 15; 95(10):1209-12. PubMed ID: 12425512
    [Abstract] [Full Text] [Related]

  • 33. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
    Schweizer C, Reu FJ, Ho AD, Hensel M.
    Ann Hematol; 2007 Oct 15; 86(10):711-7. PubMed ID: 17622529
    [Abstract] [Full Text] [Related]

  • 34. Immune thrombocytopenic purpura presenting in a patient after renal transplant for diabetic nephropathy.
    Rashid RM, Nabi Z, Ansari AZ, Qaiser QA.
    BMC Nephrol; 2018 Mar 20; 19(1):69. PubMed ID: 29554892
    [Abstract] [Full Text] [Related]

  • 35. Treatment of immune thrombocytopenic purpura in children : current concepts.
    Shad AT, Gonzalez CE, Sandler SG.
    Paediatr Drugs; 2005 Mar 20; 7(5):325-36. PubMed ID: 16220997
    [Abstract] [Full Text] [Related]

  • 36. [Diagnosis and therapy of idiopathic thrombocytopenic purpura (ITP) in adults].
    Chrobák L.
    Vnitr Lek; 2002 Aug 20; 48(8):773-80. PubMed ID: 12425210
    [Abstract] [Full Text] [Related]

  • 37. [Treatment of immune thrombocytopenia: a retrospective study of 40 patients].
    Audia S, Lakomy D, Guy J, Leguy-Seguin V, Berthier S, Aho S, Lorcerie B, Bonnotte B.
    Rev Med Interne; 2010 May 20; 31(5):337-44. PubMed ID: 20409619
    [Abstract] [Full Text] [Related]

  • 38. Treatment options for chronic refractory idiopathic thrombocytopenic purpura in adults: focus on romiplostim and eltrombopag.
    Chouhan JD, Herrington JD.
    Pharmacotherapy; 2010 Jul 20; 30(7):666-83. PubMed ID: 20575632
    [Abstract] [Full Text] [Related]

  • 39. Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study.
    Godeau B, Porcher R, Fain O, Lefrère F, Fenaux P, Cheze S, Vekhoff A, Chauveheid MP, Stirnemann J, Galicier L, Bourgeois E, Haiat S, Varet B, Leporrier M, Papo T, Khellaf M, Michel M, Bierling P.
    Blood; 2008 Aug 15; 112(4):999-1004. PubMed ID: 18463354
    [Abstract] [Full Text] [Related]

  • 40. Refractory idiopathic immune thrombocytopenic purpura in children: current and future treatment options.
    Imbach P.
    Paediatr Drugs; 2003 Aug 15; 5(12):795-801. PubMed ID: 14658921
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.